|
|
Volumn 95, Issue 14, 2003, Pages 1036-1038
|
|
Research retreat: Pfizer eliminates sugen, shrinks cancer infrastructure
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2,4 DIMETHYL 5 (2 OXO 1H INDOL 3 YLMETHYLENE) 3 PYRROLEPROPIONIC ACID;
ANTINEOPLASTIC AGENT;
BEVACIZUMAB;
ERLOTINIB;
GEFITINIB;
IMATINIB;
PROTEIN TYROSINE KINASE INHIBITOR;
SEMAXANIB;
SUNITINIB;
UNCLASSIFIED DRUG;
VASCULOTROPIN INHIBITOR;
ANGIOGENESIS INHIBITOR;
ENDOTHELIAL CELL GROWTH FACTOR;
INDOLE DERIVATIVE;
LYMPHOKINE;
NEW DRUG;
PYRROLE DERIVATIVE;
QUINAZOLINE DERIVATIVE;
SIGNAL PEPTIDE;
VASCULOTROPIN;
VASCULOTROPIN A;
CANCER RESEARCH;
CANCER THERAPY;
CLINICAL TRIAL;
COLORECTAL CANCER;
DECISION MAKING;
DRUG INDUSTRY;
DRUG RESEARCH;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
NOTE;
ORGANIZATION AND MANAGEMENT;
PATENT;
PRIORITY JOURNAL;
UNITED STATES;
ANIMAL;
ARTICLE;
DRUG ANTAGONISM;
DRUG DESIGN;
DRUG EFFECT;
GERMANY;
MEDICAL RESEARCH;
METABOLISM;
NEOPLASM;
SIGNAL TRANSDUCTION;
ANGIOGENESIS INHIBITORS;
ANIMALS;
ANTINEOPLASTIC AGENTS;
BIOMEDICAL RESEARCH;
DRUG DESIGN;
DRUG INDUSTRY;
DRUGS, INVESTIGATIONAL;
ENDOTHELIAL GROWTH FACTORS;
GERMANY;
HUMANS;
INDOLES;
INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS;
LYMPHOKINES;
NEOPLASMS;
PYRROLES;
QUINAZOLINES;
SIGNAL TRANSDUCTION;
UNITED STATES;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VASCULAR ENDOTHELIAL GROWTH FACTORS;
|
|
EID: 0043268824
PISSN: 00278874
EISSN: None
Source Type: Journal
DOI: 10.1093/jnci/95.14.1036 Document Type: Note |
|
Times cited : (4)
|
|
References (0)
|